Bring pharmaceutical and medical-supply manufacturing back to the United States and end U.S. dependence on China for essential medicines.
Stated position. What this official has said they believe on this issue — a sourced claim, shown distinctly from any assessment of what they did. It is never scored and never affects the Integrity Score.
Derived from a tracked promise: “Bring pharmaceutical and medical-supply manufacturing back to the United States and end U.S. dependence on China for essential medicines.”
Sources
- Congress.gov (Library of Congress)https://www.congress.gov/bill/119th-congress/senate-bill/1407/text ↗
“S.1407 - 119th Congress (2025-2026): ABC Safe Drug Act ... read twice and referred to the Committee on Finance.”
- Office of U.S. Senator Tom Cotton (cotton.senate.gov)https://www.cotton.senate.gov/news/op-eds/china-stole-us-capacity-to-make-drugs-we-must-take-it-back ↗
“The antidote to our dependence on Chinese drugs is to stop buying them and take back our ability to make basic medicine here in America.”
- Office of U.S. Senator Tom Cotton (cotton.senate.gov)https://www.cotton.senate.gov/news/press-releases/cotton-gallagher-introduce-bill-to-end-us-dependence-on-chinese-manufactured-pharmaceuticals ↗
“It's time to pull America's supply chains for life-saving medicine out of China and make the CCP pay for contributing to this global emergency.”
- Office of U.S. Senator Tina Smith (smith.senate.gov)https://www.smith.senate.gov/u-s-senators-tina-smith-tom-cotton-reintroduce-bipartisan-legislation-to-boost-u-s-pharmaceutical-manufacturing/ ↗
“It's time to bolster onshore manufacturing of pharmaceuticals to ensure Americans never have to rely on China for lifesaving medicine.”